# Coty Inc.: Form 10-Q for the period ended Mar 31, 2014

- Company: [Coty Inc.](/companies/coty.md) (CIK 1024305)
- Form: 10-Q
- Filed: 2014-05-14
- Accepted by EDGAR: May 14, 2014, 20:10 ET
- Period: 2014-03-31
- Accession: 0001024305-14-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1024305/000102430514000005/coty-033114x10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1024305/000102430514000005/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-01-01 to 2014-03-31 | $1.01bn | us-gaap:SalesRevenueGoodsNet |
| Revenue | 9 months, 2013-07-01 to 2014-03-31 | $3.51bn | us-gaap:SalesRevenueGoodsNet |
| Cost of revenue | 3 months, 2014-01-01 to 2014-03-31 | $395.6m | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months, 2013-07-01 to 2014-03-31 | $1.42bn | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months, 2014-01-01 to 2014-03-31 | $613.1m | us-gaap:GrossProfit |
| Gross profit | 9 months, 2013-07-01 to 2014-03-31 | $2.09bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2014-01-01 to 2014-03-31 | $543.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months, 2013-07-01 to 2014-03-31 | $1.66bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2014-01-01 to 2014-03-31 | −$272.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months, 2013-07-01 to 2014-03-31 | $37.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-01-01 to 2014-03-31 | $17.1m | us-gaap:InterestExpense |
| Interest expense | 9 months, 2013-07-01 to 2014-03-31 | $52.0m | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-01-01 to 2014-03-31 | −$40.5m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months, 2013-07-01 to 2014-03-31 | $39.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-01-01 to 2014-03-31 | −$253.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months, 2013-07-01 to 2014-03-31 | −$77.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-01-01 to 2014-03-31 | −$0.66 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months, 2013-07-01 to 2014-03-31 | −$0.20 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2014-01-01 to 2014-03-31 | −$0.66 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months, 2013-07-01 to 2014-03-31 | −$0.20 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2014-01-01 to 2014-03-31 | 384,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months, 2013-07-01 to 2014-03-31 | 384,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months, 2013-07-01 to 2014-03-31 | $443.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months, 2013-07-01 to 2014-03-31 | $165.2m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 9 months, 2013-07-01 to 2014-03-31 | $67.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2014-03-31 | $1.15bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-03-31 | $2.70bn | us-gaap:AssetsCurrent |
| Total assets | at 2014-03-31 | $6.51bn | us-gaap:Assets |
| Current liabilities | at 2014-03-31 | $1.51bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-03-31 | $5.00bn | us-gaap:Liabilities |
| Long-term debt | at 2014-03-31 | $2.74bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-03-31 | $10.0m | us-gaap:DebtCurrent |
| Shareholders' equity | at 2014-03-31 | $1.38bn | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 103,824 characters.

The following discussion and analysis of the financial condition and results of operations of Coty Inc. and its majority and wholly-owned subsidiaries, should be read in conjunction with the information contained in the Condensed Consolidated Financial Statements and related notes included elsewhere in this document, and in our other public filings with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2013 (“Fiscal 2013 Form 10-K”). When used in this discussion, the terms “Coty,” the “Company,” “we,” “our,” or “us” mean, unless the context otherwise indicates, Coty Inc. and its majority and wholly-owned subsidiaries. The following discussion contains forward-looking statements. See Part II — Item 1A. Risk Factors of our Fiscal 2013 Form 10-K for a discussion on the uncertainties, risks and assumptions associated with these statements. Actual results may differ materially from those contained in any forward-looking statements. The following discussion includes certain non-GAAP financial measures. See “Overview—Non-GAAP Financial Measures” for a discussion of non-GAAP financial measures and how they are calculated.

All dollar amounts in the following discussion are in millions of United States (“U.S.”) dollars, unless otherwise indicated.

### OVERVIEW

We are a leading global beauty company. We manufacture and market beauty products in the Fragrances, Color Cosmetics and Skin & Body Care segments with distribution in over 130 countries and territories across both prestige and mass markets. We continue to operate in a challenging market environment particularly in mass fragrance and color cosmetics with heightened promotional activities in mass retail in Western Europe and the U.S. A significant part of our strategy is to expand our geographic footprint into emerging markets and diversify our distribution channels within existing geographies to increase market presence. As part of our expansion efforts, we entered into agreements to broaden distribution in Asia, South Africa, Brazil, the United Kingdom (“U.K.”), and the United Arab Emirates (“U.A.E.”) during fiscal 2014 and our results from certain of these efforts reflect incremental net revenues from joint venture consolidations and conversion from third party to direct distribution in these geographies.

### Components of Results of Operations

#### Net Revenues

We generate revenues from the sale of our products in our Fragrances, Color Cosmetics and Skin & Body Care segments to retailers, distributors and direct sales to end users through e-commerce and other forms of direct marketing. Net revenues consist of gross revenues less customer discounts and allowances, actual and expected returns (estimated based on returns history and position in product life cycle) and various trade spending activities. Trade spending activities primarily relate to advertising, product promotions and demonstrations, some of which involve cooperative relationships with retailers and distributors.

#### Cost of Sales

Cost of sales includes all of the costs to manufacture our products. For products manufactured in our own facilities, costs include raw materials and supplies, direct labor and factory overhead. For products manufactured for us by third-party contractors, costs represent the amounts invoiced by the contractors. Cost of sales also includes royalty expense associated with license agreements, shipping costs and depreciation expense related to manufacturing equipment and facilities. In order to provide essential business services in a cost-effective manner, in some cases we outsource functions or parts of functions that can be performed more effectively by external service providers. For example, we have outsourced significant portions of our logistics management for our European business and for a component of our U.S. business, as well as certain technology-related functions, to third-party service providers.

#### Selling, General and Administrative Expenses

Selling, general and administrative expenses include advertising and consumer promotion costs, administrative costs (i.e., personnel and related expenses, research and development costs, certain warehousing fees, non-manufacturing overhead, rent on operating leases and professional fees), share-based compensation and other operating expenses.

Selling, general and administrative expenses also include the expense or benefit relating to our share-based compensation plans that are accounted for as liability plans through our initial public offering and as equity plans thereafter.

#### Marketing and Advertising Costs

Marketing and advertising costs include the aggregate of trade marketing spend activities and advertising and consumer promotional costs, which are included as a reduction to gross revenue and in Selling, general and administrative expenses, respectively, based on the counterparty. Marketing and advertising costs for the three and nine months ended March 31, 2014 and 2013 are presented below:

|  | Three Months Ended March 31, 2014 | 2013 | Nine Months Ended March 31, 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Trade marketing spend activities | $102.8 | $117.7 | $372.5 | $385.7 |
| % of Net revenues | 10.2% | 11.8% | 10.6% | 10.7% |
| Advertising and consumer promotional costs | 256.8 | 240.6 | 795.5 | 800.5 |
| % of Net revenues | 25.5% | 24.1% | 22.7% | 22.3% |
| Total marketing and advertising costs | $359.6 | $358.3 | $1,168.0 | $1,186.2 |
| % of Net revenues | 35.6% | 35.9% | 33.3% | 33.0% |

#### Income Taxes

The provision for income taxes represents federal, foreign, state and local income taxes. The effective rate differs from statutory rates due to the effect of state and local income taxes, tax rates in foreign jurisdictions and certain nondeductible expenses. Our effective tax rate will change from quarter to quarter based on recurring and nonrecurring factors including, but not limited to, the geographical mix of earnings, enacted tax legislation, state and local income taxes, tax audit settlements and the interaction of various global tax strategies. Changes in judgment from the evaluation of new information resulting in the recognition, derecognition or remeasurement of a tax position taken in a prior annual period are recognized separately in the quarter of the change.

### Non-GAAP Financial Measures

Adjusted Operating Income, Adjusted Income Before Income Taxes, Adjusted Net Income Attributable to Coty Inc. and Adjusted Net Income Attributable to Coty Inc. per Common Share are non-GAAP financial measures which we believe better enable management and investors to analyze and compare the underlying business results from period to period.

These non-GAAP financial measures should not be considered in isolation, or as a substitute for or superior to, financial measures calculated in accordance with GAAP. Moreover, these non-GAAP financial measures have limitations in that they do not reflect all the items associated with the operations of our business as determined in accordance with GAAP. We compensate for these limitations by analyzing current and future results on a GAAP basis as well as a non-GAAP basis, and we provide reconciliations from the most directly comparable GAAP financial measures to the non-GAAP financial measures. Our non-

GAAP financial measures may not be comparable to similarly titled measures of other companies. Other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently than we do, limiting the usefulness of those measures for comparative purposes.

Adjusted Operating Income, Adjusted Income Before Income Taxes, Adjusted Net Income Attributable to Coty Inc. and Adjusted Net Income Attributable to Coty Inc. per Common Share provide an alternative view of performance used by management and we believe that an investor’s understanding of our performance is enhanced by disclosing these adjusted performance measures. In addition, our financial covenant compliance calculations under our debt agreements are substantially derived from these adjusted performance measures. The following are examples of how these adjusted performance measures are utilized by management:

- senior management receives a monthly analysis of our operating results that are prepared on an adjusted performance basis;
- strategic plans and annual budgets are prepared on an adjusted performance basis; and
- senior management’s annual compensation is calculated, in part, using adjusted performance measures.

#### Adjusted Operating Income

We define Adjusted Operating Income as operating income adjusted for the following:

- Share-based compensation adjustment:
- Following June 12, 2013, the effective date of the share-based compensation plan amendments, the share-based compensation expense adjustment represents the difference between equity plan accounting using the grant date fair value and equity plan accounting using the June 12, 2013 fair value. Prior to June 12, 2013, the share-based compensation expense adjustment represents the difference between share-based compensation expense accounted for under equity plan accounting based on grant date fair value, and under liability plan accounting based on reporting date fair value.
- Future adjustments for share-based compensation will consist of the difference between expense under equity plan accounting based on the grant date fair value and total estimated share-based compensation expense, which is based on (i) the fair value on June 12, 2013 for nonqualified stock option awards and restricted stock units (“RSUs”) and (ii) all costs associated with the special incentive awards granted in fiscal 2012 and 2011. The estimated aggregate expense is $22.1, $12.3, $7.8, $2.4, and $0.2 for the fiscal years ended June 30, 2014, 2015, 2016, 2017, and 2018 respectively. Refer to “Management Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our Fiscal 2013 Form 10-K for a full discussion of the share-based compensation adjustment; and
- Other adjustments, which include:
- asset impairment charges;
- restructuring costs and business structure realignment programs;
- acquisition-related costs and certain acquisition accounting impacts; and
- other adjustments that we believe investors may find useful.

#### Adjusted Net Income and Net Income per Common Share Attributable to Coty Inc.

We define Adjusted Net Income Attributable to Coty Inc. as net income attributable to Coty Inc. adjusted for the following:

- adjustment made to reconcile operating income to Adjusted Operating Income, net of the income tax effect thereon (see Adjusted Operating Income);
- certain interest and other (income) expense, net of the income tax effect thereon, that we do not consider indicative of our performance; and
- certain tax effects that are not indicative of our performance.

Adjusted basic and diluted Net Income Attributable to Coty Inc. per Common Share is calculated as:

- Adjusted Net Income Attributable to Coty Inc. *divided by*
- Adjusted weighted-average basic and diluted common shares using the treasury stock method.

#### Constant Currency

We operate on a global basis, with the majority of our net revenues generated outside of the U.S. Accordingly, fluctuations in foreign currency exchange rates can affect our results of operations. Therefore, to supplement financial results presented in accordance with GAAP, certain financial information is presented excluding the impact of foreign currency exchange translations to provide a framework for assessing how our underlying businesses performed excluding the impact of foreign currency exchange translations (“constant currency”). Constant currency information compares results between periods as if exchange rates had remained constant period-over-period. We calculate constant currency information by translating current and prior-period results for entities reporting in currencies other than U.S. dollars into U.S. dollars using constant foreign currency exchange rates. The constant currency calculations do not adjust for the impact of revaluing specific transactions denominated in a currency that is different to the functional currency of that entity when exchange rates fluctuate. The constant currency information we present may not be comparable to similarly titled measures reported by other companies.

### RESULTS OF OPERATIONS

The following table is a comparative summary of operating results for the three and nine months ended March 31, 2014 and 2013, respectively:

*(in millions)*

| NET REVENUES By Segment: | Three Months Ended March 31, 2014 | 2013 | Nine Months Ended March 31, 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| Fragrances | $508.1 | $487.0 | $2,004.0 | $2,000.3 |
| Color Cosmetics | 344.9 | 366.7 | 990.6 | 1,083.4 |
| Skin & Body Care | 155.7 | 144.0 | 515.5 | 506.6 |
| Total | $1,008.7 | $997.7 | $3,510.1 | $3,590.3 |
| OPERATING (LOSS) INCOME |  |  |  |  |
| **By Segment:** |  |  |  |  |
| Fragrances | $54.3 | $55.5 | $350.6 | $350.3 |
| Color Cosmetics | 36.7 | 50.4 | 107.2 | 180.7 |
| Skin & Body Care (a) | (326.5) | (2.2) | (323.9) | (3.6) |
| Corporate | (36.5) | (73.6) | (96.8) | (109.1) |
| Total | $(272.0) | $30.1 | $37.1 | $418.3 |

(a) In the three months ended March 31, 2014, we recorded an asset impairment charge of $316.9, related to goodwill, identifiable intangible assets and certain tangible assets.

The following table presents our Statements of Operations, expressed as a percentage of net revenues:

|  | Three Months Ended March 31, 2014 | 2013 | Nine Months Ended March 31, 2014 | 2013 |
| --- | ---: | ---: | ---: | ---: |
| **Net revenues** | **100.0%** | **100.0%** | **100.0%** | **100.0%** |
| Cost of sales | 39.2 | 38.3 | 40.4 | 39.6 |
| **Gross Profit** | **60.8** | **61.7** | **59.6** | **60.4** |
| Selling, general and administrative expenses | 53.8 | 56.2 | 47.4 | 47.3 |
| Amortization expense | 2.1 | 2.2 | 1.8 | 1.8 |
| Restructuring costs | 0.4 | 0.3 | 0.3 | 0.1 |
| Asset impairment charges (a) | 31.5 | — | 9.0 | — |
| Gain on sale of asset | — | — | — | (0.5) |
| **Operating (Loss) Income** | **(27.0)** | **3.0** | **1.1** | **11.7** |
| Interest expense, net | 1.7 | 2.0 | 1.5 | 1.6 |
| Other income, net | (0.2) | — | (0.1) | — |
| **(Loss) Income Before Income Taxes** | **(28.5)** | **1.0** | **(0.3)** | **10.1** |
| (Benefit) provision for income taxes | (4.0) | (2.0) | 1.2 | 2.9 |
| **Net (Loss) Income** | **(24.5)** | **3.0** | **(1.5)** | **7.2** |
| Net income attributable to noncontrolling interests | 0.3 | 0.4 | 0.4 | 0.4 |
| Net income attributable to redeemable noncontrolling interests | 0.3 | 0.6 | 0.3 | 0.4 |
| **Net (Loss) Income Attributable to Coty Inc.** | **(25.1%)** | **2.0%** | **(2.2%)** | **6.4%** |

(a) In the three months ended March 31, 2014, we recorded an asset impairment charge of $316.9, related to goodwill, identifiable intangible assets and certain tangible assets.

Discussed below are our consolidated results of operations and the results of operations for each reportable segment.

### THREE MONTHS ENDED MARCH 31, 2014 AS COMPARED TO THREE MONTHS ENDED MARCH 31, 2013

NET REVENUES

In the three months ended March 31, 2014, net revenues increased 1%, or $11.0, to $1,008.7 from $997.7 in the three months ended March 31, 2013. Foreign currency exchange translations had an immaterial impact on total net revenues. The increase was primarily the result of a positive price and mix impact of 2%, partially offset by a decrease in unit volume of 1%. In fiscal 2013, one of our licenses was divested and a certain North American service agreement expired and was not renewed (“2013 Ceased Activities”). Excluding the impact to net revenues from the 2013 Ceased Activities of 1% and the impact of foreign currency exchange translations, total net revenues increased 2%.

In the three months ended March 31, 2013, net revenues were negatively affected by the impact of cancelled and unshipped orders due to certain issues arising during the quarter ended March 31, 2013 as a result of the transition to a new third-party logistics provider. These logistics issues positively impacted total net revenues growth in the three months ended March 31, 2014 by approximately 3% and impacted the Fragrances and Skin & Body Care segments in EMEA and Asia Pacific.

### Net Revenues by Segment

*(in millions)*

| NET REVENUES | Three Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| Fragrances | $508.1 | $487.0 | 4% |
| Color Cosmetics | 344.9 | 366.7 | (6%) |
| Skin & Body Care | 155.7 | 144.0 | 8% |
| **Total** | **$1,008.7** | **$997.7** | **1%** |

31

#### Fragrances

In the three months ended March 31, 2014, net revenues of Fragrances increased 4%, or $21.1, to $508.1 from $487.0 in the three months ended March 31, 2013. Foreign currency exchange translations had an immaterial impact on net revenues in Fragrances. The increase was primarily the result of an increase in unit volume of 7%, partially offset by a negative price and mix impact of 3%. Excluding the impact to net revenues from the 2013 Ceased Activities of 2%, net revenues of Fragrances increased 6%. The increase in the segment reflects higher net revenues from power brands *Calvin Klein, Davidoff,* and *Marc Jacobs* in part due to the launches of *Calvin Klein Endless Euphoria, ck one Red for Her, ck one Red for Him, Calvin Klein Downtown, Davidoff Cool Water Night Dive, Davidoff Cool Water Woman Sea Rose, Marc Jacobs Honey* and continued growth of *Marc Jacobs Daisy*. Also contributing to segment growth were incremental net revenues from newly established brands *Katy Perry Killer Queen* and *love2love* along with higher net revenues from *Jil Sander, David Beckham* and *Guess*. Partially offsetting the increase in the segment were lower net revenues from *Roberto Cavalli* and *Chloé* reflecting lower new launch activity in the three months ended March 31, 2014 relative to the strong contribution from new launches in the three months ended March 31, 2013, lower net revenues from existing celebrity brands that are later in their lifecycles and the expiration of certain licenses. The segment growth was also positively impacted by the logistics issues with a certain provider in the three months ended March 31, 2013, as previously discussed. The negative price and mix impact primarily reflects lower relative volumes of higher-priced products of select brands, such as *Roberto Cavalli* and *Chloé*, and higher relative volumes of lower-priced products sold in the mass retail channel, such as *David Beckham.*

#### Color Cosmetics

In the three months ended March 31, 2014, net revenues of Color Cosmetics decreased 6%, or $21.8, to $344.9 from $366.7 in the three months ended March 31, 2013. Foreign currency exchange translations had an immaterial impact on net revenues in Color Cosmetics. The decrease was primarily the result of a reduction in unit volume of 5% and a negative price and mix impact of 1%. The decline in the segment was primarily driven by lower net revenues from nail products, in part reflecting continued declines since the first quarter of fiscal 2014 in the U.S. retail nail market. The *Sally Hansen* brand was the largest contributor to the segment decline in part due to lower net revenues from *Sally Hansen Insta Gel* and *Sally Hansen Salon Effects* nail products that generated stronger net revenues in the three months ended March 31, 2013. Net revenues for *Sally Hansen* were also negatively affected by the aforementioned weaker demand in the nail category and decline in market share in the U.S. Partially offsetting the decline within *Sally Hansen* were higher net revenues from new launches *Sally Hansen Triple Shine* and *Sally Hansen I Heart Nail Art* nail art pens. Lower net revenues from *OPI* and *N.Y.C. New York Color* also contributed to the decline in the Color Cosmetics segment. The decrease in *OPI* primarily reflects a decline in the U.S. retail channel driven by lower net revenues of *Nicole by OPI* and the discontinuation of a particular product line sold exclusively by a large retailer. These decreases in *OPI* were partially offset by incremental net revenues in the U.K. following the acquisition of a U.K. distributor and expanded distribution in Australia. Lower net revenues from *N.Y.C. New York Color* are primarily due to a decline in the U.S. Partially offsetting the decline in the segment was an increase in *Rimmel* primarily reflecting strong growth of *Rimmel Scandal’eyes* mascara and *Rimmel Stay Matte* foundation. The negative price and mix impact for the segment primarily reflects lower relative volumes of higher-priced gel nail products and an increased level of highly promotional and discounted pricing activity in the segment, reflecting a competitive retail environment.

#### Skin & Body Care

In the three months ended March 31, 2014, net revenues of Skin & Body Care increased 8%, or $11.7, to $155.7 from $144.0 in the three months ended March 31, 2013. Foreign currency exchange translations had an immaterial impact on net revenues in Skin & Body Care. The increase was primarily the result of an increase in unit volume of 4% and a positive price and mix impact of 4%. The increase in the segment was primary driven by higher net revenues from *Lancaster, philosophy* and *adidas*. Net revenues from *Lancaster* reflect strong growth primarily due to new launches *Lancaster Self Tan Beauty* and *Lancaster Total Age Correction*, in addition to the positive impact from the logistics issues with a certain provider in the three months ended March 31, 2013, as previously discussed. Net revenues from *philosophy* increased primarily driven by higher net revenues in key distribution channels in the U.S., in part due to expanded distribution and new launches, and strong growth in Asia Pacific, in part due to expanded distribution. Net revenues from *adidas* increased reflecting strong growth in emerging markets such as Southeast Asia, China, Brazil, South Africa and the Middle East, partially offset by lower net revenues in developed markets such as Germany, the U.S. and France. Partially offsetting the increase in the segment were declines in *TJoy* as net revenues continued to decrease in spite of a reorganization of our management team and distribution network and the launch of a new ginseng product line *Hydractive.* We are considering a variety of options for our mass channel business in China; however, these measures are still in the preliminary stages, and there can be no assurance that these measures will be successful. The positive price and mix impact for the segment was primarily driven by lower relative volumes of lower-priced products such as *TJoy* and *adidas* and higher relative volumes of higher-priced products such as *Lancaster* and *philosophy.*

### Net Revenues by Geographic Regions

In addition to our reporting segments, management also analyzes our net revenues by geographic region. We define our geographic regions as Americas (comprising North, Central and South America), EMEA (comprising Europe, the Middle East and Africa) and Asia Pacific (comprising Asia and Australia).

*(in millions)*

| NET REVENUES | Three Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| Americas | $382.2 | $431.3 | (11%) |
| EMEA | 499.9 | 454.9 | 10% |
| Asia Pacific | 126.6 | 111.5 | 14% |
| **Total** | **$1,008.7** | **$997.7** | **1%** |

#### Americas

In the three months ended March 31, 2014, net revenues in the Americas decreased 11%, or $49.1, to $382.2 from $431.3 in the three months ended March 31, 2013. Excluding the negative impact of foreign currency exchange translations of 1% and the impact of net revenues related to the 2013 Ceased Activities of 1%, net revenues in the Americas decreased 9% primarily driven by lower net revenues in the U.S. The decline in the U.S. was primarily driven by lower net revenues in Color Cosmetics, primarily due to a decline in *Sally Hansen* and *OPI* as described under “Net Revenues by Segment-Color Cosmetics” above, and a decline in the Fragrances segment. Lower net revenues from Canada also contributed to the decline in the region primarily due to a decline in the Fragrances segment and the *Sally Hansen* and *Rimmel* color cosmetics brands.

#### EMEA

In the three months ended March 31, 2014, net revenues in EMEA increased 10%, or $45.0, to $499.9 from $454.9 in the three months ended March 31, 2013. Excluding the positive impact of foreign currency exchange translations of 3% and the impact of net revenues related to the 2013 Ceased Activities of 1%, net revenues in EMEA increased 8%, in part reflecting the positive impact from the logistics issues with a certain provider in the three months ended March 31, 2013, as previously discussed. Increased net revenues in the region were driven by all key markets, with the exception of Russia. The U.K. and Southern Europe led growth in EMEA. Growth in the U.K. primarily reflects strong increases in Color Cosmetics, driven by incremental net revenues from *OPI* due to the acquisition of a U.K. distributor and increased net revenues from *Rimmel*, along with the positive impact of foreign currency translations resulting from the improvement of the British Pound exchange rate. The increase in Southern Europe primarily reflects strong growth across all three segments, in part reflecting the positive impact from the logistics issues mentioned above, and the positive impact of foreign currency exchange translations resulting from the improvement of the Euro exchange rate. Also generating strong growth in the region were higher net revenues in Eastern Europe, our new subsidiary in South Africa, and the Middle East where we have transitioned to the new joint venture established in the U.A.E., reflecting our strategy of expanding our geographic footprint into emerging markets. Partially offsetting growth in EMEA were lower net revenues in Russia, in part reflecting the negative impact of the devaluation of the Russian Ruble and a more challenging retail environment. Net revenues in Germany, our largest market in the region, were positively affected by the impact from the logistics issues mentioned above and foreign currency exchange translations.

#### Asia Pacific

In the three months ended March 31, 2014, net revenues in Asia Pacific increased 14%, or $15.1, to $126.6 from $111.5 in the three months ended March 31, 2013. The negative impact of foreign currency exchange translations of approximately 5% was predominantly driven by the devaluation of the Australian Dollar. Excluding the negative impact of foreign currency exchange translations, net revenues in Asia Pacific increased 19% reflecting growth in all countries in the region. New subsidiaries in Korea, Taiwan and Southeast Asia contributed incremental net revenue growth to the region. Net revenues in Australia, our largest market in the region, were negatively affected by foreign currency exchange translations as mentioned above. Excluding the impact of foreign currency exchange translations, growth in Australia was strong, driven by increased net revenues in *Calvin Klein* and *Rimmel* along with incremental net revenues from the introduction of *OPI* and the newly established brand *Katy Perry Killer Queen*. Higher net revenues in our travel retail business, Singapore, China and Malaysia also positively impacted results in the region, primarily driven by strong growth in Fragrances. Growth in China was also driven by higher net revenues from *adidas*, partially offset by declines in the *TJoy* brand.

COST OF SALES

In the three months ended March 31, 2014, cost of sales increased 3%, or $13.0, to $395.6 from $382.6 in the three months ended March 31, 2013. Cost of sales as a percentage of net revenues increased to 39.2% in the three months ended March 31, 2014 from 38.3% in the three months ended March 31, 2013, resulting in a gross margin decline of approximately 90 basis points. The increase in cost of sales as a percentage of net revenues includes approximately 80 basis points related to the revaluation of acquired inventory. The remaining increase in cost of sales as a percentage of net revenues of 10 basis points primarily reflects the negative impact of higher customer discounts and allowances necessary to compete in the difficult market environment, reported in net revenues, and the negative impact of foreign currency exchange transactions, partially offset by continued contribution from our supply chain savings program, reported in cost of sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the three months ended March 31, 2014, selling, general and administrative expenses decreased 3%, or $16.9, to $543.2 from $560.1 in the three months ended March 31, 2013. Selling, general and administrative expenses as a percentage of net revenues decreased to 53.8% in the three months ended March 31, 2014 from 56.2% in the three months ended March 31, 2013. This decrease of approximately 240 basis points includes approximately 480 basis points related to lower share-based compensation expense adjustment, acquisition-related costs and public entity preparedness costs, partially offset by higher real estate consolidation program costs and other business realignment costs. See “Adjusted Operating Income.” Excluding the items described above, selling, general and administrative expenses increased 6%, or $29.6, to $518.8 from $489.2 in the three months ended March 31, 2013 and increased as a percentage of net revenues to 51.4% from 49.0%. The increase of 240 basis points primarily reflects higher advertising and consumer promotion spending, higher accruals related to the management incentive program and investment in our new subsidiaries in emerging markets, partially offset by lower discretionary costs reflecting our focus on cost containment in developed markets.

OPERATING INCOME

In the three months ended March 31, 2014, operating income decreased $302.1, to $(272.0) from $30.1 in the three months ended March 31, 2013. Operating margin, or operating income as a percentage of net revenues, decreased to (27.0)% of net revenues in the three months ended March 31, 2014 as compared to 3.0% in the three months ended March 31, 2013. This margin decline primarily reflects the impact of asset impairment charges in our Skin & Body Care segment. Also contributing to margin decline was approximately 90 basis points related to higher cost of sales and approximately 10 basis points of higher restructuring expense. Partially offsetting this decline was 240 basis points driven by lower selling, general and administrative expenses and approximately 10 basis points related to lower amortization expense.

### Operating Income by Segment

*(in millions)*

| OPERATING (LOSS) INCOME | Three Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| Fragrances | $54.3 | $55.5 | (2%) |
| Color Cosmetics | 36.7 | 50.4 | (27%) |
| Skin & Body Care (a) | (326.5) | (2.2) | \<(100%) |
| Corporate | (36.5) | (73.6) | 50% |
| **Total** | **$(272.0)** | **$30.1** | **\<(100%)** |

(a) In the three months ended March 31, 2014, we recorded an asset impairment charge of $316.9, related to goodwill, identifiable intangible assets and certain tangible assets.

#### Fragrances

In the three months ended March 31, 2014, operating income for Fragrances decreased 2%, or $1.2, to $54.3 from $55.5 in the three months ended March 31, 2013. Operating margin decreased to 10.7% of net revenues in the three months ended March 31, 2014 as compared to 11.4% in the three months ended March 31, 2013, primarily driven by higher cost of sales, partially offset by lower selling, general and administrative expenses as a percentage of net revenues.

#### Color Cosmetics

In the three months ended March 31, 2014, operating income for Color Cosmetics decreased 27%, or $13.7, to $36.7 from $50.4 in the three months ended March 31, 2013. The decrease in operating income reflects lower net revenues and a decline in operating margin. Operating margin decreased to 10.6% of net revenues in the three months ended March 31, 2014 as compared to 13.7% in the three months ended March 31, 2013, primarily driven by higher selling, general and administrative expenses as a percentage of net revenues primarily due to higher advertising and consumer promotion spending.

#### Skin & Body Care

In the three months ended March 31, 2014, operating loss for Skin & Body Care increased $324.3, to $(326.5) from $(2.2) in the three months ended March 31, 2013, primarily reflecting asset impairment charges of $316.9. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment.

Excluding asset impairment charges, operating loss increased $7.4, to $(9.6) from $(2.2) in the three months ended March 31, 2014. Operating margin decreased to (6.2)% of net revenues in the three months ended March 31, 2014 as compared to (1.5)% in the three months ended March 31, 2013, primarily driven by higher selling, general and administrative expenses as a percentage of net revenues primarily due to higher advertising and consumer promotion spending partially offset by lower amortization expense as a percentage of net revenues.

#### Corporate

Corporate primarily includes corporate expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the three months ended March 31, 2014, operating loss for Corporate was $36.5 compared to $73.6 in the three months ended March 31, 2013, as described under “Adjusted Operating Income” below.

### Adjusted Operating Income

We believe that Adjusted Operating Income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to Adjusted Operating Income is presented below:

*(in millions)*

|  | Three Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | --- |
| **Reported Operating (Loss) Income** | **$(272.0)** | **$30.1** | **\<(100%)** |
| % of Net revenues | (27.0%) | 3.0% |  |
| Asset impairment charges | 316.9 | — | N/A |
| Real estate consolidation program costs | 13.4 | 5.4 | \>100% |
| Acquisition-related costs | 9.3 | 8.8 | 6% |
| Restructuring and other business realignment costs | 7.3 | 3.6 | \>100% |
| Share-based compensation expense adjustment | 6.5 | 55.1 | (88%) |
| Public entity preparedness costs | — | 0.7 | (100%) |
| Total adjustments to Reported Operating (Loss) Income | 353.4 | 73.6 | \>100% |
| **Adjusted Operating Income** | **$81.4** | **$103.7** | **(22%)** |
| % of Net revenues | 8.1% | 10.4% |  |

In the three months ended March 31, 2014, Adjusted Operating Income decreased 22%, or $22.3, to $81.4 from $103.7 in the three months ended March 31, 2013. Adjusted operating margin decreased to 8.1% of net revenues in the three months ended March 31, 2014 as compared to 10.4% in the three months ended March 31, 2013, driven by higher selling, general and administrative expenses and cost of sales as a percentage of net revenues, partially offset by lower amortization expense. Excluding the impact of foreign currency exchange translations, Adjusted Operating Income decreased 20%.

#### Asset Impairment Charges

In the three months ended March 31, 2014, we incurred asset impairment charges of $316.9. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment. In the course of evaluating the results and preparing the financial statements for the three months ended March 31, 2014, we determined that net cash outflows associated with the TJoy mass channel business in China were significantly in excess of previous expectations in spite of a reorganization of our management team and distribution network and the launch of new product offerings through which we anticipated realizing significant improvements in cash flows beginning in the three months ended March 31, 2014.

In the three months ended March 31, 2013, we did not incur any asset impairment charges.

#### Real Estate Consolidation Program Costs

In the three months ended March 31, 2014, we incurred $13.4 of costs in connection with the consolidation of real estate in New York. The real estate consolidation program costs primarily consist of $12.6 of lease loss expense and $0.9 of duplicative rent expense. We expect to continue to incur additional costs associated with the consolidation of real estate in New York during the remainder of fiscal 2014. We expect the real estate consolidation program to be completed in fiscal 2014.

In the three months ended March 31, 2013, we incurred $5.4 of costs in connection with the consolidation of real estate in New York. The real estate consolidation program costs primarily consist of $4.1 of accelerated depreciation and $1.1 of duplicative rent expense.

In all reported periods, all real estate consolidation program costs were recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and were included in Corporate.

#### Acquisition-Related Costs

In the three months ended March 31, 2014, we incurred acquisition-related costs of $9.3. These costs include $8.5 of costs primarily related to acquisition accounting impacts of revaluation of acquired inventory, included in cost of sales in the Condensed Consolidated Statements of Operations and $0.8 of costs which primarily consist of costs related to certain completed business combinations, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the three months ended March 31, 2013, we incurred acquisition-related costs of $8.8. These costs primarily include $6.7 of costs related to an additional charge related to the revised estimated arbitration settlement amount based on the progress of the proceedings between us and the seller of TJoy and costs of $2.0 which primarily consist of costs related to certain completed and/or contemplated business combinations, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all acquisition-related costs were reported in Corporate.

#### Restructuring and Other Business Realignment Costs

In the three months ended March 31, 2014, we incurred restructuring and other business structure realignment costs of $7.3.

In the three months ended June 30, 2013, our Board of Directors approved a number of business integration and productivity initiatives aimed at enhancing long-term operating margins (the “Productivity Program”), as described in Note 6, “Restructuring Costs” in the notes to Condensed Consolidated Financial Statements. We anticipate completing the implementation of all project activities by fiscal 2016. The total charge associated with the Productivity Program is expected to be approximately $70.0 to $75.0, of which $35.6 has been incurred through March 31, 2014. In the three months ended March 31, 2014, restructuring costs in the Condensed Consolidated Statement of Operations reflect $4.0 of costs related to the Productivity Program and $(0.1) related to changes in estimates for other restructuring costs.

In the three months ended March 31, 2014, we incurred business structure realignment costs of $3.4. These costs include $3.7 primarily related to certain other programs, included in selling, general and administrative expenses in the Condensed

Consolidated Statements of Operations and $0.3 of income due to the change in estimates related to integration expenses, included in cost of sales in the Condensed Consolidated Statements of Operations.

In the three months ended March 31, 2013, we incurred restructuring and other business structure realignment costs of $3.6, consisting of $2.7 included in restructuring costs in the Condensed Consolidated Statement of Operations for a service agreement that expired and was not renewed, where we provided selected selling, distribution and administrative services in return for a commission based fee and $0.9 related to certain other programs in North America, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

#### Share-Based Compensation Adjustment

Share-based compensation expense adjustment included in the calculation of the Adjusted Operating Income was $6.5 and $55.1 in the three months ended March 31, 2014 and 2013, respectively. The decrease in the share-based compensation expense adjustment primarily reflects the impact of the accounting modification from liability plan accounting to equity plan accounting as of June 12, 2013, the effective date of the share-based compensation plan amendments. In the three months ended March 31, 2013, the higher share-based compensation expense was the result of the increase in the estimated fair value of our Class A Common Stock from $15.25 as of December 31, 2012 to $17.00 as of March 31, 2013.

Senior management evaluates operating performance of our segments based on the share-based expense calculated under equity plan accounting for the recurring stock option awards, share-based awards, and director-owned and employee-owned shares, and we follow the same treatment of the share-based compensation for the financial covenant compliance calculations under our debt agreements. See “Overview—Non-GAAP Financial Measures.” Share-based compensation expense calculated under equity plan accounting for the recurring nonqualified stock option awards and director-owned and employee-owned shares, restricted shares, and RSUs is reflected in the operating results of the segments. Share-based compensation adjustment is included in Corporate. See Note 3, “Segment Reporting” in our notes to Condensed Consolidated Financial Statements.

#### Public Entity Preparedness Costs

In the three months ended March 31, 2013, we incurred public entity preparedness costs of $0.7 primarily consisting of consulting and legal fees associated with preparation and filing of the registration statement for our initial public offering.

In all reported periods, all public entity preparedness costs were recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and were included in Corporate.

INTEREST EXPENSE, NET

In the three months ended March 31, 2014, interest expense, net was $17.3 as compared with $20.2 in the three months ended March 31, 2013. The decrease in expense primarily relates to lower interest expense on our debt instruments of $3.0, and an increase in interest income of $0.3, partially offset by an increase in losses related to foreign exchange of $0.4, net of derivative foreign exchange contracts.

INCOME TAXES

The effective income tax rate for the three months ended March 31, 2014 and 2013 is 14.1% and (196.0%), respectively. The variations in the effective tax rates for the three month periods were primarily due the negative impact associated with asset impairment charges which provided minimal tax benefits and the positive effects of the reversal of certain unrecognized tax benefits approximating $38.1 million for the three months ended March 31, 2014 compared to a one-time tax benefit of $23.8 million related to American Taxpayer Relief Act of 2012 on January 2, 2013, which extended retroactively Internal Revenue Code Section 954(c)(6) for the three months ended March 31, 2013.

The effective rates vary from the U.S. federal statutory rate of 35% due to the effect of (1) jurisdictions with different statutory rates, (2) adjustments to our unrecognized tax benefits and accrued interest, (3) non-deductible expenses and (4) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

### Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:

*(in millions)*

|  | Three Months Ended March 31, 2014 Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate |  | Three Months Ended March 31, 2013 Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate |  |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: | --- |
| **Reported (Loss) Income Before Income Taxes** | **$(287.2)** | **$(40.5)** | **14.1%** |  | **$10.1** | **$(19.8)** | **(196.0%)** |  |
| Adjustments to Reported Operating (Loss) Income (a) | 353.4 | 13.4 |  |  | 73.6 | 25.6 |  |  |
| **Adjusted Income Before Income Taxes** | **$66.2** | **$(27.1)** | **(40.9%)** | **(b)** | **$83.7** | **$5.8** | **6.9%** | **(c)** |

(a) See “Overview—Non-GAAP Financial Measures” for further information.

(b) The Company's normalized tax rate excluding the benefits associated with the expiration of statutes of limitation and audit settlements was 19.8% for the three months ended March 31, 2014.

(c) The Company's normalized tax rate excluding the benefits associated with the extension of 954c(6) was 35.4%.

The adjusted effective tax rate was (40.9%) compared to 6.9% in the prior-year period. The adjusted effective tax rate for the three months ended March 31, 2014 was primarily impacted by the reversal of certain unrecognized tax benefits associated with the settlement of tax audits in multiple foreign jurisdictions. The adjusted effective tax rate for the three months ended March 31, 2013 was primarily impacted by the passage of the American Taxpayer Relief Act of 2012 on January 2, 2013, which extended retroactively Internal Revenue Code Section 954(c)(6). Cash paid during the quarter for income taxes of $9.6 and $24.4, represents 14.5% and 29.2% of Adjusted income before income taxes for the three months ended March 31, 2014 and March 31, 2013, respectively.

NET INCOME ATTRIBUTABLE TO COTY INC.

In the three months ended March 31, 2014, net income attributable to Coty Inc. decreased $273.7, to $(253.3), from $20.4 in the three months ended March 31, 2013. This decrease primarily reflects lower operating income, partially offset by lower interest expense and lower tax expense as described in “Interest Expense, Net” and “Income Taxes” above.

We believe that Adjusted Net Income Attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”

*(in millions)*

|  | Three Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| **Reported Net (Loss) Income Attributable to Coty Inc.** | **$(253.3)** | **$20.4** | **\<(100%)** |
| % of Net revenues | (25.1%) | 2.0% |  |
| Adjustments to Reported Operating (Loss) Income (a) | 353.4 | 73.6 | \>100% |
| Change in tax provision due to adjustments to Reported Net (Loss) Income Attributable to Coty Inc. | (13.4) | (25.6) | 48% |
| **Adjusted Net Income Attributable to Coty Inc.** | **$86.7** | **$68.4** | **27%** |
| % of Net revenues | 8.6% | 6.9% |  |
| **Per Share Data** |  |  |  |
| Adjusted weighted-average common shares (b) |  |  |  |
| Basic | 384.0 | 382.8 |  |
| Diluted | 392.0 | 396.7 |  |
| Adjusted net income attributable to Coty Inc. per common share (c) |  |  |  |
| Basic | $0.23 | $0.18 |  |
| Diluted | 0.22 | 0.17 |  |

38

(a) See “Reconciliation of Operating Income to Adjusted Operating Income” in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

(b) In the three months ended March 31, 2014, using the treasury stock method, the number of adjusted diluted common shares to calculate non-GAAP adjusted diluted net income per common share was 8.0 million higher than the number of common shares used to calculate GAAP diluted net loss per common share, due to the potentially dilutive effect of certain securities issuable under our share-based compensation plans, which were considered anti-dilutive for calculating GAAP diluted net loss per common share. In the three months ended March 31, 2013, the adjusted number of common shares used to calculate non-GAAP adjusted basic and diluted net income attributable to Coty Inc. per common share is identical to the number of common and diluted shares used to calculate GAAP net income (loss) per common share.

(c) The current cash tax benefit associated with the amortization of goodwill and other intangible assets for OPI and Philosophy was $6.0 for the three months ended March 31, 2014 and 2013, respectively. This tax benefit is not reflected in Adjusted Net Income Attributable to Coty Inc. The impact of this tax benefit per share is $0.02 for the three months ended March 31, 2014 and 2013, respectively.

### NINE MONTHS ENDED MARCH 31, 2014 AS COMPARED TO NINE MONTHS ENDED MARCH 31, 2013

NET REVENUES

In the nine months ended March 31, 2014, net revenues decreased 2%, or $80.2, to $3,510.1 from $3,590.3 in the nine months ended March 31, 2013. The decrease was primarily the result of a decline in unit volume of 2%. Foreign currency exchange translations and price and mix had an immaterial impact on total net revenues. The 2013 Ceased Activities had an immaterial impact on total net revenues growth.

In the nine months ended March 31, 2013, net revenues were negatively affected by the impact of cancelled and unshipped orders due to certain issues arising during the quarter ended March 31, 2013 as a result of the transition to a new third-party logistics provider. These logistics issues partially offset the total net revenues decline in the nine months ended March 31, 2014 by approximately 1% and impacted the Fragrances and Skin & Body Care segments in EMEA and Asia Pacific.

### Net Revenues by Segment

*(in millions)*

| NET REVENUES | Nine Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| Fragrances | $2,004.0 | $2,000.3 | — |
| Color Cosmetics | 990.6 | 1,083.4 | (9%) |
| Skin & Body Care | 515.5 | 506.6 | 2% |
| **Total** | **$3,510.1** | **$3,590.3** | **(2%)** |

#### Fragrances

In the nine months ended March 31, 2014, net revenues of Fragrances increased $3.7 to $2,004.0 from $2,000.3 in the nine months ended March 31, 2013. Foreign currency exchange translations had an immaterial impact on net revenues in Fragrances. An increase in unit volume of 2% was offset by a negative price and mix impact of 2%. Excluding the impact to net revenues from the 2013 Ceased Activities of 1%, net revenues of Fragrances increased 1%. Segment growth was primarily driven by incremental net revenues from the newly established brand *Katy Perry Killer Queen* and higher net revenues from *Roberto Cavalli, Davidoff* and *Calvin Klein* in part due to the launches of *Just Cavalli for Him, Roberto Cavalli Nero Assoluto, Davidoff Cool Water Woman Sea Rose, Davidoff Cool Water Night Dive, Davidoff the Game, Calvin Klein Downtown* and *Calvin Klein Endless Euphoria*. Power brands *Marc Jacobs* and *Chloé* also positively impacted segment results in part due to the launches of *Marc Jacobs Honey, Roses de Chloé* and continued growth of *Marc Jacobs Daisy*. Also contributing to segment growth were higher net revenues from *Nautica, Botega Venetta, Guess, David Beckham*, and *Jil Sander*. The segment growth was also positively impacted by the logistics issues with a certain provider in the nine months ended March 31, 2013, as previously discussed. Partially offsetting the increase in the segment was a decline in net revenues from *Lady Gaga* and *Beyoncé* due to a lower level of new launch activity for these two brands in the nine months ended March 31, 2014 compared to the nine months ended March 31, 2013, the expiration of certain licenses and lower net revenues from existing celebrity brands that are later in their lifecycles. Power brand, *Playboy*, also negatively impacted segment results in part due lower holiday customer orders in the nine months ended March 31, 2014 compared to the nine months ended March 31, 2013. The negative price and mix impact primarily reflects an overall increased level of highly promotional and discounted pricing activity, reflecting a competitive retail environment.

#### Color Cosmetics

In the nine months ended March 31, 2014, net revenues of Color Cosmetics decreased 9%, or $92.8, to $990.6 from $1,083.4 in the nine months ended March 31, 2013. The decrease was primarily the result of a negative price and mix impact of 5%, a decline in unit volume of 3% and a negative impact of foreign currency exchange translations of 1%. The decline in the segment was primarily driven by lower net revenues from nail products, in part reflecting continued declines since the first quarter of fiscal 2014 in the U.S. retail nail market. The *Sally Hansen* brand was the largest contributor to the segment decline, in part due to several key U.S. mass retailers significantly reducing their inventory on hand in response to the sudden decline in consumer demand for nail products, resulting in lower replenishment orders in the nine months ended March 31, 2014 compared to the nine months ended March 31, 2013. Also contributing to the decline in *Sally Hansen* were lower net revenues from *Sally Hansen Insta Gel* and *Sally Hansen Salon Effects* nail products that generated stronger net revenues in the nine months ended March 31, 2013, partially offset by higher net revenues from new launch *Sally Hansen Triple Shine* and *Sally Hansen I Heart Nail Art* nail art pens in the nine months ended March 31, 2014. Net revenues for *Sally Hansen* were also negatively affected by an increasingly competitive retail environment, decline in market share and the aforementioned weaker demand in the nail category in the U.S. Lower net revenues from *OPI* also contributed to the decline in the Color Cosmetics segment, reflecting a decline in the U.S. retail channel driven by lower net revenues of *Nicole by OPI* and the discontinuation of a particular product line sold exclusively by a large retailer. These decreases in *OPI* were partially offset by incremental net revenues attributable to new distribution with a professional salon chain in the U.S., incremental net revenues in the U.K. following the acquisition of a U.K. distributor, expanded distribution in Australia and strong growth in our travel retail business. Partially offsetting the decline in the segment was an increase in *Rimmel* primarily reflecting strong growth of *Rimmel Scandal’eyes* mascara and *Rimmel Stay Matte* foundation. The negative price and mix impact for the segment was primarily driven by unit price declines in most key brands within the segment primarily driven by an increased level of highly promotional and discounted pricing activity, reflecting a competitive retail environment.

#### Skin & Body Care

In the nine months ended March 31, 2014, net revenues of Skin & Body Care increased 2%, or $8.9, to $515.5 from $506.6 in the nine months ended March 31, 2013. The increase was primarily driven by a positive price and mix impact of 5% and a positive impact of foreign currency exchange translations of 1%, partially offset by a decline in unit volume of 4%. Excluding the positive impact of foreign currency exchange translations, net revenues of Skin & Body Care increased 1% driven by higher net revenues from *philosophy, Lancaster* and *adidas*. Net revenues from *philosophy* increased primarily driven by higher net revenues in key distribution channels in the U.S., in part due to expanded distribution and new launches, and strong growth in Asia Pacific and the U.K., in part due to expanded distribution. Net revenues from *Lancaster* reflect strong growth primarily due to new launches *Lancaster Self Tan Beauty* and *Lancaster Total Age Correction*, in addition to the positive impact from the logistics issues with a certain provider in the three months ended March 31, 2013, as previously discussed. Net revenues from *adidas* increased reflecting strong growth in emerging markets such as Southeast Asia, Brazil, China, and South Africa, partially offset by lower net revenues in developed markets such as Southern Europe, Germany, and the Netherlands. Partially offsetting the increase in the segment were declines in *TJoy* as net revenues continued to decrease in spite of a reorganization of our management team and distribution network and the launch of a new ginseng product line *Hydractive.* We are considering a variety of options for our mass channel business in China; however, these measures are still in the preliminary stages, and there can be no assurance that these measures will be successful. The positive price and mix impact for the segment was primarily driven by lower relative volumes of lower-priced *TJoy* products and higher relative volumes of higher-priced *philosophy* and *Lancaster* products.

### Net Revenues by Geographic Regions

In addition to our reporting segments, management also analyzes our net revenues by geographic region. We define our geographic regions as Americas (comprising North, Central and South America), EMEA (comprising Europe, the Middle East and Africa) and Asia Pacific (comprising Asia and Australia).

*(in millions)*

| NET REVENUES | Nine Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| Americas | $1,312.1 | $1,485.1 | (12%) |
| EMEA | 1,769.6 | 1,690.7 | 5% |
| Asia Pacific | 428.4 | 414.5 | 3% |
| **Total** | **$3,510.1** | **$3,590.3** | **(2%)** |

#### Americas

In the nine months ended March 31, 2014, net revenues in the Americas decreased 12%, or $173.0, to $1,312.1 from $1,485.1 in the nine months ended March 31, 2013. Excluding the negative impact of foreign currency exchange translations of 1% and the impact of net revenues related to the 2013 Ceased Activities of 1%, net revenues in the Americas decreased 10% primarily driven by lower net revenues in the U.S. The decline in the U.S. was largely driven by lower net revenues in Color Cosmetics, primarily due to a decline in *Sally Hansen* and *OPI* as described under “Net Revenues by Segment-Color Cosmetics” above, and Fragrances. The decline in Fragrances in the U.S. primarily reflects lower net revenues from *Lady Gaga* and *Beyoncé*, due to a lower level of new launch activity in the nine months ended March 31, 2014 compared to the nine months ended March 31, 2013, the expiration of certain licenses, lower net revenues from existing celebrity brands that are later in their lifecycles and a decline in mature products in our power brands *Playboy, Chloé, Davidoff* and *Calvin Klein.* Lower net revenues from Canada also contributed to the decline in the region, in part reflecting a decrease in *Lady Gaga*, due to a lower level of new launch activity in the nine months ended March 31, 2014 compared to the nine months ended March 31, 2013, *Sally Hansen* and *Balenciaga*, partially offset by incremental net revenues from the newly established brand *Katy Perry Killer Queen*. Slightly offsetting the decline in the Americas were higher net revenues in Brazil, primarily reflecting the impact of our new joint venture and commercial partnership, and our travel retail business in the region, primarily due to growth from fragrances in the prestige market and *OPI.*

#### EMEA

In the nine months ended March 31, 2014, net revenues in EMEA increased 5%, or $78.9, to $1,769.6 from $1,690.7 in the nine months ended March 31, 2013. Excluding the positive impact of foreign currency exchange translations of 3% and the impact of net revenues related to the 2013 Ceased Activities of 1%, net revenues in EMEA increased 3%. Growth in EMEA was primarily driven by the U.K., Eastern Europe, Germany, and our new subsidiary in South Africa, reflecting our strategy of expanding our geographic footprint into emerging markets. Growth in the region was also positively impacted by the logistics issues with a certain provider in the nine months ended March 31, 2013, as previously discussed. Higher net revenues in the U.K. reflected incremental net revenues from *OPI* resulting from the acquisition of a U.K. distributor and from newly established brand *Katy Perry Killer Queen*, strong growth from *Rimmel* and *David Beckham*, along with the positive impact of foreign currency translations resulting from the improvement of the British Pound exchange rate. Higher net revenues in Eastern Europe primarily reflect strong growth in our power brands, *Calvin Klein, Rimmel, Davidoff*, and *adidas* along with incremental net revenues from the newly established brand *Katy Perry Killer Queen*, in addition to the positive impact of foreign currency exchange translations. Net revenues in Germany, our largest market in the region, were positively impacted by the favorable comparison due to the logistics issues mentioned above and foreign currency exchange translations. Excluding the impact of foreign currency exchange translations and the net revenues related to the 2013 Ceased Activities, net revenues in Germany declined primarily driven by lower net revenues from *Rimmel*, in part due to the planned withdrawal of the brand in the market, and a decline in *adidas*. Partially offsetting growth in the region were lower net revenues in Russia, in part reflecting the negative impact of the devaluation of the Russian Ruble and a more challenging retail environment.

#### Asia Pacific

In the nine months ended March 31, 2014, net revenues in Asia Pacific increased 3%, or $13.9, to $428.4 from $414.5 in the nine months ended March 31, 2013. The negative impact of foreign currency exchange translations of approximately 5% was predominantly driven by the devaluation of the Australian Dollar and Japanese Yen. Excluding the negative impact of foreign currency exchange translations, net revenues in Asia Pacific increased 8%. New subsidiaries in Taiwan, Korea and Southeast Asia contributed incremental net revenue growth to the region. Higher net revenues in Hong Kong and Singapore also positively impacted results, primarily reflecting growth in Fragrances. Results in the region were adversely impacted by lower net revenues in Japan and China. Lower net revenues in Japan primarily reflected the negative impact of foreign currency exchange translations as mentioned above. The decline in China was primarily driven by lower net revenues from *TJoy,* partially offset by growth in Fragrances, *adidas*, and *Lancaster*. Net revenues in Australia, our largest market in the region, were negatively affected by foreign currency exchange translations as mentioned above. Excluding the impact of foreign currency exchange translations, higher net revenues in Australia primarily reflected growth in Fragrances, *Rimmel* and incremental net revenues from the introduction of *OPI.*

COST OF SALES

In the nine months ended March 31, 2014, cost of sales decreased $5.0, to $1,416.9 from $1,421.9 in the nine months ended March 31, 2013. Cost of sales as a percentage of net revenues increased to 40.4% in the nine months ended March 31, 2014 from 39.6% in the nine months ended March 31, 2013, resulting in a gross margin decline of approximately 80 basis points. The increase in cost of sales as a percentage of net revenues includes approximately 30 basis points related to the revaluation of acquired inventory. The remaining increase in cost of sales as a percentage of net revenues of approximately 50 basis points primarily reflects the negative impact of higher customer discounts and allowances necessary to compete in the difficult market environment, reported in net revenues, and the negative impact of foreign currency exchange transactions, partially offset by continued contribution from our supply chain savings program, reported in cost of sales.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

In the nine months ended March 31, 2014, selling, general and administrative expenses decreased 2%, or $35.8, to $1,662.6 from $1,698.4 in the nine months ended March 31, 2013. Selling, general and administrative expenses as a percentage of net revenues increased to 47.4% in the nine months ended March 31, 2014 from 47.3% in the nine months ended March 31, 2013. This increase of 10 basis points includes approximately 120 basis points related to lower share-based compensation expense adjustment and public entity preparedness costs partially offset by higher real estate consolidation program costs, acquisition-related costs and other business realignment costs. See “Adjusted Operating Income.” Excluding the items described above, selling, general and administrative expenses increased 1%, or $11.9, to $1,586.5 from $1,574.6 in the nine months ended March 31, 2013 and increased as a percentage of net revenues to 45.2% from 43.9%. This increase of 130 basis points primarily reflects our investment in new subsidiaries in emerging markets, higher accruals related to the management incentive program and higher advertising and consumer promotion spending, partially offset by lower discretionary costs reflecting our focus on cost containment in developed markets.

OPERATING INCOME

In the nine months ended March 31, 2014, operating income decreased 91%, or $381.2, to $37.1 from $418.3 in the nine months ended March 31, 2013. Operating margin, or operating income as a percentage of net revenues, decreased to 1.1% of net revenues in the nine months ended March 31, 2014 as compared to 11.7% in the nine months ended March 31, 2013. This margin decline primarily reflects the impact of asset impairment charges in our Skin & Body Care segment. Also contributing to margin decline was approximately 80 basis points driven by higher cost of sales, approximately 50 basis points due to the gain on sale of assets in the nine months ended March 31, 2013 not repeated in the nine months ended March 31, 2014, approximately 20 basis points related to higher restructuring expense and approximately 10 basis points due to higher selling, general and administrative expenses.

### Operating Income by Segment

*(in millions)*

| OPERATING INCOME (LOSS) | Nine Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| Fragrances | $350.6 | $350.3 | — |
| Color Cosmetics | 107.2 | 180.7 | (41%) |
| Skin & Body Care (a) | (323.9) | (3.6) | \<(100%) |
| Corporate | (96.8) | (109.1) | 11% |
| **Total** | **$37.1** | **$418.3** | **(91%)** |

(a) In the nine months ended March 31, 2014, we recorded an asset impairment charge of $316.9, related to goodwill, identifiable intangible assets and certain tangible assets.

#### Fragrances

In the nine months ended March 31, 2014, operating income for Fragrances increased $0.3, to $350.6 from $350.3 in the nine months ended March 31, 2013. Operating margin of 17.5% in the nine months ended March 31, 2014 remained consistent with the nine months ended March 31, 2013.

#### Color Cosmetics

In the nine months ended March 31, 2014, operating income for Color Cosmetics decreased 41%, or $73.5, to $107.2 from $180.7 in the nine months ended March 31, 2013. The decrease in operating income reflects lower net revenues and a decline in operating margin. Operating margin decreased to 10.8% of net revenues in the nine months ended March 31, 2014 as compared to 16.7% in the nine months ended March 31, 2013, primarily driven by higher selling, general and administrative expenses and cost of sales as percentages of net revenues primarily due to higher advertising and consumer promotion spending.

#### Skin & Body Care

In the nine months ended March 31, 2014, operating loss for Skin & Body Care increased $320.3, to $(323.9) from $(3.6) in the nine months ended March 31, 2013, primarily reflecting asset impairment charges of $316.9. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment.

Excluding asset impairment charges, operating loss increased 94%, or $3.4, to $(7.0) from $(3.6) in the nine months ended March 31, 2014. Operating margin decreased to (1.4)% of net revenues in the nine months ended March 31, 2014 as compared to (0.7%) in the nine months ended March 31, 2013, primarily driven by higher selling, general and administrative expenses primarily due to higher advertising and consumer promotion spending partially offset by lower cost of sales and amortization expense as percentages of net revenues.

#### Corporate

Corporate primarily includes corporate expenses not directly relating to our operating activities. These items are included in Corporate since we consider them to be Corporate responsibilities, and these items are not used by our management to measure the underlying performance of the segments.

In the nine months ended March 31, 2014, operating loss for Corporate was $96.8 compared to $109.1 in the nine months ended March 31, 2013, as described under “Adjusted Operating Income” below.

### Adjusted Operating Income

We believe that Adjusted Operating Income further enhances an investor’s understanding of our performance. See “Overview—Non-GAAP Financial Measures.” Reconciliation of reported operating income to Adjusted Operating Income is presented below:

*(in millions)*

|  | Nine Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| **Reported Operating Income** | **$37.1** | **$418.3** | **(91%)** |
| % of Net revenues | 1.1% | 11.7% |  |
| Asset impairment charges | 316.9 | 1.5 | \>100% |
| Real estate consolidation program costs | 32.4 | 16.1 | \>100% |
| Acquisition-related costs | 26.8 | 9.4 | \>100% |
| Share-based compensation expense adjustment | 19.9 | 89.1 | (78%) |
| Restructuring and other business realignment costs | 16.5 | 8.1 | \>100% |
| Public entity preparedness costs | 1.2 | 4.2 | (71%) |
| Gain on sale of asset | — | (19.3) | 100% |
| Total adjustments to Reported Operating Income | 413.7 | 109.1 | \>100% |
| **Adjusted Operating Income** | **$450.8** | **$527.4** | **(15%)** |
| % of Net revenues | 12.8% | 14.7% |  |

43

In the nine months ended March 31, 2014, Adjusted Operating Income decreased 15%, or $76.6, to $450.8 from $527.4 in the nine months ended March 31, 2013. Adjusted operating margin decreased to 12.8% of net revenues in the nine months ended March 31, 2014 as compared to 14.7% in the nine months ended March 31, 2013, primarily driven by higher selling, general and administrative expenses and cost of sales as a percentage of net revenues. Excluding the impact of foreign currency exchange translations, Adjusted Operating Income decreased 14%.

#### Asset Impairment Charges

In the nine months ended March 31, 2014, we incurred asset impairment charges of $316.9. The impairment represents the write-off of goodwill, identifiable intangible assets and certain tangible assets associated with the Beauty - Skin & Body Care reporting unit which is included in the Skin & Body Care segment. In the course of evaluating the results and preparing the financial statements for the three months ended March 31, 2014, we determined that net cash outflows associated with the TJoy mass channel business in China were significantly in excess of previous expectations in spite of a reorganization of our management team and distribution network and the launch of new product offerings through which we anticipated realizing significant improvements in cash flows beginning in the three months ended March 31, 2014.

In the nine months ended March 31, 2013, we incurred a loss on sale of $1.5 in connection with the sale of a manufacturing facility. These charges were recorded in asset impairment charges in the Condensed Consolidated Statements of Operations and were included in Corporate.

#### Real Estate Consolidation Program Costs

In the nine months ended March 31, 2014, we incurred $32.4 of costs in connection with the consolidation of real estate in New York. The real estate consolidation program costs primarily consist of $21.5 of lease loss expense, $5.0 of duplicative rent expense and $4.4 of depreciation. We expect to continue to incur additional costs associated with the consolidation of real estate in New York during the remainder of fiscal 2014. We expect the real estate consolidation program to be completed in fiscal 2014.

In the nine months ended March 31, 2013, we incurred $16.1 of costs in connection with the consolidation of real estate in New York. The real estate consolidation program costs primarily consist of $12.1 of accelerated depreciation and $3.1 of duplicative rent expense.

In all reported periods, all real estate consolidation program costs were recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and were included in Corporate.

#### Acquisition-Related Costs

In the nine months ended March 31, 2014, we incurred acquisition-related costs of $26.8. These costs primarily include $15.2 of fees related to the termination of a pre-existing manufacturing and distribution contract in South Africa after forming our wholly-owned subsidiary in South Africa and $1.1 of costs related to certain completed and/or contemplated business combinations included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations, and $10.5 of costs related to acquisition accounting impacts of revaluation of acquired inventory, included in cost of sales in the Condensed Consolidated Statements of Operations.

In the nine months ended March 31, 2013, we incurred acquisition-related costs of $9.4. These costs primarily include $6.7 of costs related to an additional charge related to a revised estimated arbitration settlement amount based on the progress of the proceedings between us and the seller of TJoy, $2.0 of costs related to certain completed and/or contemplated business combinations, and $0.7 of internal integration costs, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all acquisition-related costs were reported in Corporate.

#### Share-Based Compensation Adjustment

Share-based compensation expense adjustment included in the calculation of the Adjusted Operating Income was $19.9 and $89.1 in the nine months ended March 31, 2014 and 2013, respectively. The decrease in the share-based compensation expense adjustment in the nine months ended March 31, 2014 primarily reflects the impact of the accounting modification from liability plan accounting to equity plan accounting as of June 12, 2013, the effective date of the share-based compensation plan amendments. In the nine months ended March 31, 2013, the higher share-based compensation expense was the result of the increase in the estimated fair value of our Class A Common Stock from $14.25 as of June 30, 2012 to $17.00 as of March 31, 2013, as well as a modification to the Executive Ownership Plan (“EOP”) in December 2012 which resulted in an acceleration of share-based compensation expense.

Senior management evaluates operating performance of our segments based on the share-based expense calculated under equity plan accounting for the recurring stock option awards, share-based awards, and director-owned and employee-owned shares, and we follow the same treatment of the share-based compensation for the financial covenant compliance calculations under our debt agreements. See “Overview—Non-GAAP Financial Measures.” Share-based compensation expense calculated under equity plan accounting for the recurring nonqualified stock option awards and director-owned and employee-owned shares, restricted shares, and RSUs is reflected in the operating results of the segments. Share-based compensation adjustment is included in Corporate. See Note 3, “Segment Reporting” in our notes to Condensed Consolidated Financial Statements.

#### Restructuring and Other Business Realignment Costs

In the nine months ended March 31, 2014, we incurred restructuring and other business structure realignment costs of $16.5.

In the three months ended June 30, 2013, our Board of Directors approved a number of business integration and productivity initiatives aimed at enhancing long-term operating margins (the “Productivity Program”), as described in Note 6, “Restructuring Costs” in the notes to Condensed Consolidated Financial Statements. We anticipate completing the implementation of all project activities by fiscal 2016. The total charge associated with the Productivity Program is expected to be approximately $70.0 to $75.0, of which $35.6 has been incurred through March 31, 2014. In the nine months ended March 31, 2014, restructuring costs in the Condensed Consolidated Statement of Operations reflect $10.3 of costs related to the Productivity Program and $(0.1) related to changes in estimates for other restructuring costs.

In the nine months ended March 31, 2014, we incurred business structure realignment costs of $6.3 related to certain other programs, of which $0.4 consisted of accelerated depreciation, included in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In the nine months ended March 31, 2013, we incurred restructuring and other business structure realignment costs of $8.1, consisting of $3.1 included in restructuring costs in the Condensed Consolidated Statement of Operations for a service agreement that expired and was not renewed, where we provided selected selling, distribution and administrative services in return for a commission based fee, and $5.0 in business structure realignment costs. These business structure realignment costs include $2.2 related to position eliminations in certain administrative functions, $2.1 primarily related to certain other programs in North America, of which $0.9 consisted of accelerated depreciation, and $0.7 related to structural reorganization in Geneva related to the creation of a fragrance “Center of Excellence” for research and development and the centralization of global supply chain management in Geneva. These costs were recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations.

In all reported periods, all restructuring and other business realignment costs were reported in Corporate.

#### Public Entity Preparedness Costs

In the nine months ended March 31, 2014, we incurred public entity preparedness costs of $1.2 primarily consisting of a third-party expense reimbursement to JAB Holdings B.V., which is the successor to JAB Holdings II B.V., Berkshire Partners LLC and Rhône Capital L.L.C. as described in “Certain Relationships and Related Transaction, and Director Independence -- Third-Party Expenses” in Part III, Item 13 of our Fiscal 2013 Form 10-K and remaining miscellaneous costs associated with our initial public offering.

In the nine months ended March 31, 2013, we incurred public entity preparedness costs of $4.2 primarily consisting of consulting and legal fees associated with preparation and filing of the registration statement for our initial public offering.

In all reported periods, all public entity preparedness costs were recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations and were included in Corporate.

#### Gain on Sale of Asset

In the nine months ended March 31, 2013, we received $25.0 related to the termination of one of our licenses by mutual agreement with the original licensor. The license had a net book value of $5.7 and, therefore, we recorded a gain of $19.3 in gain on sale of assets in the Condensed Consolidated Statements of Operations and included in Corporate.

INTEREST EXPENSE, NET

In the nine months ended March 31, 2014, interest expense, net was $51.4 as compared with $55.5 in the nine months ended March 31, 2013. The decrease in expense primarily relates to lower interest expense on our debt instruments of $7.5, and an increase in interest income of $0.2, partially offset by an increase in losses related to foreign exchange of $3.6, net of derivative foreign exchange contracts.

INCOME TAXES

The effective income tax rate for the nine months ended March 31, 2014 and 2013 was (328.3%) and 29.0%, respectively. The variations in the effective tax rates for the nine-month periods are primarily due to the negative impact associated with asset impairment charges which provided minimal tax benefits and the positive effects of the reversal of certain unrecognized tax benefits, approximating $38.1 million, associated with the settlement of tax audits in multiple foreign jurisdictions.

The effective rates vary from the U.S. federal statutory rate of 35% due to the effect of (1) jurisdictions with different statutory rates, (2) adjustments to our unrecognized tax benefits and accrued interest, (3) non-deductible expenses and (4) valuation allowance changes. Our effective tax rate could fluctuate significantly and could be adversely affected to the extent earnings are lower than anticipated in countries that have lower statutory rates and higher than anticipated in countries that have higher statutory rates.

### Reconciliation of Reported Income Before Income Taxes to Adjusted Income Before Income Taxes and Effective Tax Rates:

*(in millions)*

|  | Nine Months Ended March 31, 2014 Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate |  | Nine Months Ended March 31, 2013 Income Before Income Taxes | Provision for Income Taxes | Effective Tax Rate |
| --- | ---: | ---: | ---: | --- | ---: | ---: | ---: |
| **Reported Income Before Income Taxes** | **$(12.0)** | **$39.4** | **(328.3%)** |  | **$363.4** | **$105.3** | **29.0%** |
| Adjustments to Reported Operating Income (a) | 413.7 | 30.1 |  |  | 109.1 | 26.1 |  |
| **Adjusted Income Before Income Taxes** | **$401.7** | **$69.5** | **17.3%** | **(b)** | **$472.5** | **$131.4** | **27.8%** |

(a) See “Overview—Non-GAAP Financial Measures” for further information.

(b) The Company's normalized tax rate excluding the benefits associated with the expiration of statutes of limitation and audit settlements was 27.9% for the nine months ended March 31, 2014.

The adjusted effective tax rate was 17.3% compared to 27.8% in the prior-year period. The decrease was a result of reversal of certain unrecognized tax benefits associated with the settlement of tax audits in multiple foreign jurisdictions. Cash paid during the nine months ended March 31, 2014 and 2013, for income taxes of $59.3 and $66.7, represents 14.8% and 14.1% of Adjusted income before income taxes for the nine months ended, respectively.

NET INCOME ATTRIBUTABLE TO COTY INC.

In the nine months ended March 31, 2014, net income attributable to Coty Inc. decreased $307.6, to $(77.3), from $230.3 in the nine months ended March 31, 2013. This decrease primarily reflects lower operating income partially offset by lower interest expense and lower tax expense as described in “Interest Expense, Net” and “Income Taxes” above.

We believe that Adjusted Net Income Attributable to Coty Inc. provides an enhanced understanding of our performance. See “Overview—Non-GAAP Financial Measures.”

*(in millions)*

|  | Nine Months Ended March 31, 2014 | 2013 | Change % |
| --- | ---: | ---: | ---: |
| **Reported Net (Loss) Income Attributable to Coty Inc.** | **$(77.3)** | **$230.3** | **\<(100%)** |
| % of Net revenues | (2.2%) | 6.4% |  |
| Adjustments to Reported Operating Income (a) | 413.7 | 109.1 | \>100% |
| Change in tax provision due to adjustments to Reported Net (Loss) Income Attributable to Coty Inc. | (30.1) | (26.1) | (15%) |
| **Adjusted Net Income Attributable to Coty Inc.** | **$306.3** | **$313.3** | **(2%)** |
| % of Net revenues | 8.7% | 8.7% |  |
| **Per Share Data** |  |  |  |
| Adjusted weighted-average common shares (b) |  |  |  |
| Basic | 384.1 | 381.2 |  |
| Diluted | 392.9 | 396.7 |  |
| Adjusted net income attributable to Coty Inc. per common share (c) |  |  |  |
| Basic | $0.80 | $0.82 |  |
| Diluted | 0.78 | 0.79 |  |

(a) See “Reconciliation of Operating Income to Adjusted Operating Income” in Item 2, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

(b) In the nine months ended March 31, 2014, using the treasury stock method, the number of adjusted diluted common shares to calculate non-GAAP adjusted diluted net income per common share was 8.8 million higher than the number of common shares used to calculate GAAP diluted net loss per common share, due to the potentially dilutive effect of certain securities issuable under our share-based compensation plans, which were considered anti-dilutive for calculating GAAP diluted net loss per common share. In the nine months ended March 31, 2013, the adjusted number of common shares used to calculate non-GAAP adjusted basic and diluted net income attributable to Coty Inc. per common share is identical to the number of common and diluted shares used to calculate GAAP net income (loss) per common share.

(c) The current cash tax benefit associated with the amortization of goodwill and other intangible assets for OPI and Philosophy was $18.1 and $17.9 for the nine months ended March 31, 2014 and 2013, respectively. This tax benefit is not reflected in Adjusted Net Income Attributable to Coty Inc. The impact of this tax benefit per share is $0.05 for the nine months ended March 31, 2014 and 2013, respectively.

### FINANCIAL CONDITION

LIQUIDITY AND CAPITAL RESOURCES

### Overview

Our primary sources of funds include cash generated from operations, borrowings from issuance of debt and committed and uncommitted lines of credit provided by banks and lenders in the U.S. and abroad. As of March 31, 2014, we had cash and cash equivalents of $1,147.2 compared with $920.4 at June 30, 2013.

Our cash flows are subject to seasonal variation throughout the year, including demands on cash made during our first fiscal quarter in anticipation of higher global sales during the second quarter and strong cash generation in the second fiscal quarter as a result of increased demand by retailers associated with the holiday season. Our principal uses of cash are to fund planned operating expenditures, capital expenditures, interest payments, acquisitions, dividends, share repurchases and any principal payments on debt. The working capital movements are based on the sourcing of materials related to the production of our Fragrances, Color Cosmetics, and Skin & Body Care products.

As a result of the cash on hand, our ability to generate cash from operations and through access to our revolving credit facility and other lending sources, we believe we have sufficient liquidity to meet our ongoing needs on both a near term and long-term basis.

### Cash Flows

| Condensed Consolidated Statements of Cash Flows Data: (in millions) | Nine Months Ended March 31, 2014 | 2013 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $443.1 | $362.5 |
| Net cash used in investing activities | (224.3) | (184.7) |
| Net cash used in financing activities | (32.6) | (3.6) |

#### Net cash provided by operating activities

Net cash provided by operating activities was $443.1 and $362.5 for the nine months ended March 31, 2014 and 2013, respectively, an increase of $80.6. The increase in operating cash inflows is due to an increase in accounts payable of $137.4 as a result of Company initiatives to obtain more favorable vendor payment terms, an increase in accrued expenses and other current liabilities primarily due to lower bonus payments of $56.8 and the elimination of cash exercises related to share-based compensation programs of $42.5 as a result of shared-based compensation plan amendments upon our initial public offering at the end of fiscal 2013. These inflows were partially offset by lower cash provided by operating income of $43.5 and the related decrease in tax accruals of $7.2 and the reversal of certain unrecognized tax benefits associated with the settlement of tax audits in multiple foreign jurisdictions of $36.0, and a decrease in net working capital items of $66.6 partially attributable to an increase in prepaid advertising for fiscal 2014 launches and other miscellaneous items and also higher cash outflows from other noncurrent assets of $33.3 attributable to timing of advance royalty payments made to a licensor during the second quarter of fiscal 2014.

#### Net cash used in investing activities

Net cash used in investing activities was $224.3 and $184.7 for the nine months ended March 31, 2014, and 2013, respectively. The increase in cash outflows is primarily driven by a decrease in proceeds from the sale of an asset of $25.0, which occurred in fiscal 2013, related to the termination of one of our licenses by mutual agreement with the original licensor and higher capital expenditure spending of $11.7 during the nine months ended March 31, 2014. During the nine months ended March 31, 2014, we had cash outflows related to acquisitions of $29.5 related to two business combinations. During the nine months ended March 31, 2013, we had cash outflows of $26.2 for the payments of $18.2 for the remaining 8% of the TJoy shares and acquisition of a celebrity fragrance license for $8.0.

#### Net cash used in financing activities

Net cash used in financing activities was $32.6 and $3.6 for the nine months ended March 31, 2014 and 2013, respectively. The increase in financing cash outflows of $29.0 is primarily due to $67.6 cash outflow for our new share repurchase program in fiscal 2014 and higher dividend payments of $19.5, offset by lower net repayments on our debt instruments of $42.1.

### Contractual Obligations and Commitments

#### License agreements

During the nine months ended March 31, 2014, we amended a certain license agreement which resulted in the prepayment of certain royalty and advertising and promotional spend obligations of $25.7 and $5.4, respectively, and reduced future commitments by approximately $3.5 annually through 2022.

#### Redeemable Noncontrolling Interests

On September 20, 2013, we amended the shareholder agreement governing our UAE Subsidiary. The amendment will reduce the percentage of our Call right and percentage of the noncontrolling interest holder’s put right to sell the non-controlling interest to us as of July 1, 2014. As part of the amendment we exercised our Call right for 7% of the UAE Subsidiary, which we intend to consummate on July 1, 2014. We estimate we will pay approximately $16.6 for this 7%.

### Dividends

On September 17, 2013, we announced a cash dividend of $0.20 per share, or $77.6 on our Class A and Class B Common Stock. Of the $77.6, $76.9 was paid on October 31, 2013 to holders of record of Class A and Class B Common Stock on

October 11, 2013 and is recorded as a decrease to APIC in the Condensed Consolidated Balance Sheet as of March 31, 2014. The remaining $0.7 is payable upon settlement of RSUs and vesting of restricted shares of Class A Common Stock, each outstanding as of October 11, 2013, and is recorded as Other noncurrent liabilities in the Condensed Consolidated Balance Sheet.

Additionally, we reduced the dividend accrual recorded in a prior period by $0.2 to adjust for accrued dividends on RSUs no longer expected to vest, which was recorded as an increase to APIC in the Condensed Consolidated Balance Sheet. Total accrued dividends on unvested RSUs of $0.9 are included in Other noncurrent liabilities in the Condensed Consolidated Balance Sheet as of March 31, 2014.

### Restructuring Activities

The productivity program is progressing as planned. We continue to target annual savings of $60.0 by FY16. Additionally, we are currently evaluating our operating model to identify additional areas for simplification and standardization.

### Share Repurchase

On February 12, 2014, the Board of Directors authorized the repurchase by the Company of shares of Class A Common Stock having an aggregate market value not exceeding $200.0. In connection with the new program (“Share Repurchase Program”), the Company repurchased 4.5 million shares of its Class A Common Stock during the three months ended March 31, 2014. The shares were purchased in multiple transactions at prices ranging from $14.64 to $15.63. The fair value of all shares repurchased was $67.6 and was reflected as an increase to Treasury stock in the Company’s Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Equity and Redeemable Noncontrolling Interests.

### Off-Balance Sheet Arrangements

We had undrawn letters of credit of $3.9 and $3.3 as of March 31, 2014 and June 30, 2013, respectively.

### Critical Accounting Policies

We believe that the critical accounting policies listed below involve our more significant judgments, assumptions and estimates and, therefore, could have the greatest potential impact on our condensed consolidated financial statements.

- Revenue Recognition
- Goodwill, Other Intangible Assets and Long-Lived Assets
- Pension and Other Post-Employment Benefit Costs
- Share-Based Compensation
- Income Taxes

As of March 31, 2014, there have been no material changes to the items disclosed as critical accounting policies and estimates in “Management Discussion and Analysis of Financial Condition and Results of Operations” in Part II—Item 7 of our Fiscal 2013 Form 10-K, except as noted below.

Based on the May 1, 2013 annual impairment test, the fair value of Beauty - Skin & Body Care Reporting Unit exceeded its carrying value by 26.4%. During the third quarter of fiscal 2014, we experienced net cash outflows associated with the TJoy mass channel business in China that were significantly in excess of previous expectations in spite of a reorganization of our management team and distribution network in China and the launch of new product offerings through which we anticipated realizing significant improvements in cash flows beginning in the third quarter. In the course of evaluating the results for the third quarter and the preparation of third quarter financial statements, management concluded that the results in China represented an indicator of impairment that warranted an interim impairment test for goodwill and certain other intangible assets in the Beauty - Skin & Body Care Reporting Unit.

In step one of the goodwill impairment test, we identified that the carrying value of the reporting unit exceeded its fair value based on a re-evaluation of discounted cash flows and confirmed by using a market approach to value the reporting units. The main drivers of the decline were a decrease in average net sales growth rates for the reporting unit from high-single digits to mid-single digits and an increase in weighted average cost of capital, based on management's recent estimates.

In the preliminary step two of the test the implied fair value of goodwill was determined by comparing the fair value of the other assets in the reporting unit to the fair value of the reporting unit. Predominantly as a result of the fair value of the adidas license, the implied fair value of goodwill was determined to be nil. Consequently, goodwill was fully impaired, resulting in a reduction in fair value of the Beauty - Skin & Body Care reporting unit of 43.4% from May 1, 2013 fair value and a total non-cash impairment charge of $316.9, of which $256.4 related to goodwill and $60.5 to other assets. The preliminary step two test is incomplete, due to the significant amount of work required to calculate the implied fair value of goodwill and due to the timing of the identification of the interim impairment indicators. The items in the step two test that are incomplete include, but are not limited to, determining the valuation of inventory and property, plant and equipment in the reporting unit.

Concurrently with the evaluation of future cash flows of the reporting unit, the Company also re-evaluated future cash flows from other long lived assets in China, consisting of the TJoy trademark, customer relationships and a manufacturing facility, with a total carrying value of $69.1. It was determined that the carrying value of this asset group exceeded its fair value resulting in an impairment charge of $60.5. The TJoy trademark and customer relationships of $21.0 and $33.5, respectively, were fully impaired and the remaining $6.0 impairment charge was attributable to the reduction of the carrying value of a manufacturing facility.

There were no impairments of goodwill at other reporting units during the third quarter of fiscal 2014. Based on the impairment test performed as of May 1, 2013, the Company determined that the fair values of its other reporting units significantly exceeded their respective carrying values at that date by a range of 40% to greater than 100%. Thus, a significant decrease in fair value would be required before the goodwill balance at other reporting units would have a carrying value in excess of fair value.

The Company believes the assumptions used in calculating the estimated fair values of the other reporting units are reasonable and attainable. However, the Company can provide no assurances that it will achieve such projected results. Further, the Company can provide no assurances that it will not have to recognize additional impairment of goodwill in the future due to other market conditions or changes in interest rates in these other reporting units. Recognition of additional impairment of a significant portion of the Company’s goodwill would negatively affect the Company’s reported results of operations and total capitalization.

### Forward Looking Statements

Certain statements in this Quarterly Report on Form 10-Q are forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, our future operations and financial performance; expected growth; our ability to support our planned business operation on a near- and long-term basis. These forward-looking statements are generally identified by words or phrases, such as “anticipate”, “estimate”, “plan”, “project”, “expect”, “believe”, “intend”, “foresee”, “forecast”, “will”, “may”, “should,” “outlook,” “continue,” “target,” “aim” and similar words or phrases.

Reported results should not be considered an indication of future performance, and actual results may differ materially from the results predicted due to risks and uncertainties including:

- our ability to achieve our global business strategy and compete effectively in the beauty industry;
- our ability to anticipate, gauge and respond to market trends and consumer preferences, which may change rapidly;
- our ability to identify suitable acquisition targets and managerial, integration, operational and financial risks associated with those acquisitions;
- risks related to our international operations, including reputational, regulatory, economic and foreign political risks such as the political risks such as the political instability in Russia and Ukraine;
- dependence on certain licenses, entities performing outsourced functions and third-party suppliers;
- our and our brand partners’ and licensors’ ability to obtain, maintain and protect the intellectual property rights used in our products and our abilities to protect our respective reputations;
- impairments to our goodwill and other assets;
- global political and/or economic uncertainties or disruptions, including a general economic downturn and economic environment in Europe, a sudden disruption in business conditions affecting consumer purchases of our products, volatility in the financial markets and fluctuations in currency exchange rates;
- our ability to manage seasonal variability;
- consolidation among retailers, shifts in consumers’ preferred distribution channels, and other changes in the retail environment in which we sell our products;
- disruptions in operations;
- increasing dependency on information technology and our ability to protect against service interruptions, data corruption, cyber-based attacks or network security breaches;
- changes in laws, regulations and policies that affect our business or products;
- market acceptance of new product introductions; and
- the illegal distribution and sale by third parties of counterfeit versions of our products.

More information about potential risks and uncertainties that could affect our business and financial results is included under Item 1A. Risk Factors in our Fiscal 2013 Form 10-K.

We assume no responsibility to update forward-looking statements made herein or otherwise.

### Industry, Ranking and Market Data

Unless otherwise indicated, information contained in this Quarterly Report on Form 10-Q concerning our industry and the market in which we operate, including our general expectations about our industry, market position, market opportunity and market size, is based on data from various sources including internal data and estimates as well as third-party sources widely available to the public such as independent industry publications (including Euromonitor International Ltd), government publications, reports by market research firms or other published independent sources and on our assumptions based on that data and other similar sources. We did not fund and are not otherwise affiliated with the third-party sources that we cite. Industry publications and other published sources generally state that the information contained therein has been obtained from third-party sources believed to be reliable. Internal data and estimates are based upon information obtained from trade and business organizations and other contacts in the markets in which we operate and management’s understanding of industry conditions, and such information has not been verified by any independent sources. These data involve a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. While we believe the market, industry and other information included in this Quarterly Report on Form 10-Q to be the most recently available and to be generally reliable, such information is inherently imprecise and we have not independently verified any third-party information or verified that more recent information is not available.

We refer to North America, Western Europe and Japan as “developed markets,” and all other markets as “emerging markets.” Except as specifically indicated, all references to rankings are based on retail value market share.

Our fiscal year ends on June 30. Unless otherwise noted, any reference to a year preceded by the word “fiscal” refers to the fiscal year ended June 30 of that year. For example, references to “fiscal 2014” refer to the fiscal year ended June 30, 2014. Any reference to a year not preceded by “fiscal” refers to a calendar year.

## Market risk

As filed, 181 characters.

There have been no material changes in market risk from the information provided in Item 7A. Quantitative and Qualitative Disclosures About Market Risk of our Fiscal 2013 Form 10-K.

## Controls and procedures

As filed, 3,523 characters.

### Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as defined in Rules 13a-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to our management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Our management, with the participation of our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2014. Based on the evaluation of our disclosure controls and procedures as of March 31, 2014, our CEO and CFO concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.

### Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting identified in management’s evaluation pursuant to Rules 13a-15(f) of the Exchange Act during the third fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

### Inherent Limitations on Effectiveness of Controls

Our management, including our CEO and CFO, believes that our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving our objectives and are effective at the reasonable assurance level. However, our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Filed May 14, 2014.
Source: SEC EDGAR, the filing index for accession 0001024305-14-000005. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.
